Comparison of utilization and cost of healthcare services and pharmacotherapy following implantation of vagus nerve stimulation vs. responsive neurostimulation or deep brain stimulation for the treatment of drug-resistant epilepsy: analyses of a large United States healthcare claims database.
Tom VincentQian LiLu ZhangMichael StokesVanessa DanielsonJoanna MurphyFrancesca BarionSandi LamReginald LassagneAriel BergerPublished in: Journal of medical economics (2022)
After matching, VNS was associated with significantly lower all-cause and epilepsy-related costs for the two-year period following implantation. All-cause and epilepsy-related costs remained statistically significantly lower for VNS even after costs of implantation were excluded.